Dabrafenib plus trametinib combination therapy in pediatric patients with BRAF V600-mutant low-grade glioma: Safety and efficacy results.

被引：0
|
作者：
Geoerger, Birgit
Bouffet, Eric
Whitlock, James A.
Moertel, Christopher L.
Hargrave, Darren R.
Aerts, Isabelle
Cohen, Kenneth J.
Kilburn, Lindsay Baker
Wright, Karen D.
Choi, Jeea
Gasal, Eduard
Russo, Mark W.
Fox, Elizabeth
机构：
[1] Univ Paris Saclay, Gustave Roussy Canc Ctr, Villejuif, France
[2] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada
[3] Univ Minnesota, Masonic Childrens Hosp, Minneapolis, MN USA
[4] UCL Great Ormond St Inst Child Hlth, London, England
[5] PSL Res Univ, Inst Curie, Oncol Ctr SIREDO, Paris, France
[6] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
[7] Childrens Natl Hosp, Washington, DC USA
[8] Boston Childrens Canc & Blood Disorders Ctr, Dana Farber Canc Inst, Boston, MA USA
[9] Novartis Pharmaceut, E Hanover, NJ USA
[10] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10506
引用
收藏
页数：2
相关论文
共 50 条
  • [41] COMBI-MB: A phase II study of combination dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600-mutant (mut) melanoma brain metastases (MBM).
    Davies, Michael A.
    Robert, Caroline
    Long, Georgina V.
    Grob, Jean Jacques
    Flaherty, Keith T.
    Arance, Ana
    Chiarion-Sileni, Vanna
    Thomas, Luc
    Lesimple, Thierry
    Mortier, Laurent
    Moschos, Stergios J.
    Hogg, David
    Rodas, Ivan Marquez
    Del Vecchio, Michele
    Lebbe, Celeste
    Meyer, Nicolas
    Zhang, Ying
    Huang, Yingjie
    Mookerjee, Bijoyesh
    Saiag, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with BRAF V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial COMBI-i)
    Tawbi, Hussein A.
    Robert, Caroline
    Brase, Jan C.
    Gusenleitner, Daniel
    Gasal, Eduard
    Garrett, James
    Savchenko, Alexander
    Gorgun, Gullu
    Flaherty, Keith T.
    Ribas, Antoni
    Dummer, Reinhard
    Schadendorf, Dirk
    Long, Georgina, V
    Nathan, Paul D.
    Ascierto, Paolo A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (06)
  • [43] Real-world efficacy and safety data for dabrafenib and trametinib combination therapy in Japanese patients with BRAF V600 mutation-positive advanced melanoma
    Takahashi, Akira
    Namikawa, Kenjiro
    Nakano, Eiji
    Yamazaki, Naoya
    JOURNAL OF DERMATOLOGY, 2020, 47 (03): : 257 - 264
  • [44] Dabrafenib, Alone or in Combination with Trametinib, in Pediatric Patients with BRAF V600 Mutation-Positive Langerhans Cell Histiocytosis
    Whitlock, James A.
    Geoerger, Birgit
    Roughton, Michael
    Choi, Jeea
    Osterloh, Lisa
    Russo, Mark
    Hargrave, Darren
    BLOOD, 2021, 138
  • [45] Effect of first-line spartalizumab plus dabrafenib plus trametinib on immunosuppressive features detected in peripheral blood and clinical outcome in patients (pts) with advanced BRAF V600-mutant melanoma.
    Dummer, Reinhard
    Biette, Kelly
    Gusenleitner, Daniel
    Ramesh, Radha
    Lebbe, Celeste
    Atkinson, Victoria
    Mandala, Mario
    Nathan, Paul D.
    Arance, Ana
    Richtig, Erika
    Yamazaki, Naoya
    Robert, Caroline
    Schadendorf, Dirk
    Tawbi, Hussein Abdul-Hassan
    Ascierto, Paolo Antonio
    Ribas, Antoni
    Flaherty, Keith
    Gasal, Eduard
    Brase, Jan C.
    Long, Georgina V.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [46] Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600-Mutant Stage III Melanoma
    Hauschild, Axel
    Dummer, Reinhard
    Schadendorf, Dirk
    Santinami, Mario
    Atkinson, Victoria
    Mandala, Mario
    Chiarion-Sileni, Vanna
    Larkin, James
    Nyakas, Marta
    Dutriaux, Caroline
    Haydon, Andrew
    Robert, Caroline
    Mortier, Laurent
    Schachter, Jacob
    Lesimple, Thierry
    Plummer, Ruth
    Dasgupta, Kohinoor
    Haas, Tomas
    Shilkrut, Mark
    Gasal, Eduard
    Kefford, Richard
    Kirkwood, John M.
    Long, Georgina V.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (35) : 3441 - +
  • [47] MANAGEMENT OF ADVERSE EVENTS IN PATIENTS WITH BRAF V600E-MUTANT NON-SMALL CELL LUNG CANCER TREATED WITH COMBINATION DABRAFENIB PLUS TRAMETINIB
    Wallace, Deborah
    Skotte, Emily
    Johnson, Douglas
    Horn, Leora
    ONCOLOGY NURSING FORUM, 2018, 45 (02)
  • [48] BRAF V600E Status Alone Is Not Sufficient as a Prognostic Biomarker in Pediatric Low-Grade Glioma
    Jones, David T. W.
    Witt, Olaf
    Pfister, Stefan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (01) : 96 - +
  • [49] Phase 1/2 study assessing the safety and efficacy of dabrafenib and trametinib combination therapy in Japanese patients with BRAF V600 mutation-positive advanced cutaneous melanoma
    Yamazaki, Naoya
    Tsutsumida, Arata
    Takahashi, Akira
    Namikawa, Kenjiro
    Yoshikawa, Shusuke
    Fujiwara, Yutaka
    Kondo, Shunsuke
    Mukaiyama, Akihira
    Zhang, Fanghong
    Kiyohara, Yoshio
    JOURNAL OF DERMATOLOGY, 2018, 45 (04): : 397 - 407
  • [50] Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study
    Bai, Xue
    Shaheen, Ahmed
    Grieco, Charlotte
    d'Arienzo, Paolo D.
    Mina, Florentia
    Czapla, Juliane A.
    Lawless, Aleigha R.
    Bongiovanni, Eleonora
    Santaniello, Umberto
    Zappi, Helena
    Dulak, Dominika
    Williamson, Andrew
    Lee, Rebecca
    Gupta, Avinash
    Li, Caili
    Si, Lu
    Ubaldi, Martina
    Yamazaki, Naoya
    Ogata, Dai
    Johnson, Rebecca
    Park, Benjamin C.
    Jung, Seungyeon
    Madonna, Gabriele
    Hochherz, Juliane
    Umeda, Yoshiyasu
    Nakamura, Yasuhiro
    Gebhardt, Christoffer
    Festino, Lucia
    Capone, Mariaelena
    Ascierto, Paolo Antonio
    Johnson, Douglas B.
    Lo, Serigne N.
    Long, Georgina L.
    Menzies, Alexander M.
    Namikawa, Kenjiro
    Mandala, Mario
    Guo, Jun
    Lorigan, Paul
    Najjar, Yana G.
    Haydon, Andrew
    Quaglino, Pietro
    Boland, Genevieve M.
    Sullivan, Ryan J.
    Furness, Andrew J. S.
    Plummer, Ruth
    Flaherty, Keith T.
    ECLINICALMEDICINE, 2023, 65
12345